Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086156

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086156

Eye Health Supplement Market, by Ingredients Type, by Indication Type, by Dosage Type by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

PUBLISHED:
PAGES: 223 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Eye health is a growing concern, owing to increased screen time & digital exposure. Common problems include eye strain, dry & red eyes, eye irritation, and watery eyes. Moreover, common eye diseases include age- related macular degeneration, cataract, and glaucoma. Age-related macular degeneration is an eye disease that gets severe over the time. The disease does not cause blindness but can cause severe problem for vision. Some of the major symptoms of eye problems are less clear vision, and worse colour perception. Cataract occurs when eye's natural lens becomes cloudy. Proteins present in the eyes breaks down and this causes things to look blurry, hazy or less colourful. Some of the major symptoms of cataract are blurry eyes vision, seeing double, and having trouble to see at night. Glaucoma is the condition of eye disease that damages eye's optic nerve. Glaucoma is related to build up of pressure inside the eyes. The increased pressure can cause damage to optic nerve, if the damage is severe glaucoma can cause permanent vision loss. Some of the major symptoms of glaucoma are redness in eyes, eye pain, and seeing halos around light. Doctors prescribe medicines for eye related diseases such as cataract, glaucoma, and others which include ingredients such as Lutein and zeaxanthin, Omega-3 fatty acids, Vitamin A, Beta-carotene, and bilberry extracts.

Market Dynamics

Approval of new products by the regulatory bodies is expected to propel growth of the global eye health supplement market during the forecast period. For instance, in September 2021, Foods with Function Claims (FFC) approved the Lutemax 2000, an eye supplement containing Lutein and Zeaxanthin in Japan. Lutemax 2000 is indicated to support eye health, reduced eye fatigue, and improved visual performance.

However, since there are various tests for the diagnosis of eye diseases, this will increase the cost of the treatment, this is expected to hinder the market growth. For example, clinicians use slit lamp findings such as lid observations, tear meniscus height, and corneal staining for diagnosis of dry eye disease.

Key features of the study:

  • This report provides in-depth analysis of the global eye health supplement market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022 - 2028), considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global eye health supplement market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include: Pfizer, Inc., Bausch Health Companies Inc., Alcon Laboratories, Inc., Alliance Pharma PLC, Allied Biotech Corporation, BASF SE, Amway Corp., Butterflies Healthcare Ltd, Herballife Nutrition Ltd., SUSS Technology Corp., Eyescience Labs, Nordic Naturals, Vitabiotics Ltd., and Akorn Incorporated
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global eye health supplement market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for eye health supplement market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Eye Health Supplement Market, By Ingredients Type:
    • Lutein and Zeaxanthin
    • Omega-3 Fatty Acids
    • Vitamin A
    • Beta- carotene
    • BilBerry extracts
    • Others
  • Global Eye Health Supplement Market, By Indication Type:
    • Age-related Macular Degeneration (AMD)
    • Cataract
    • Dry Eye Syndrome
    • Glaucoma
    • Others
  • Global Eye Health Supplement Market, By Dosage Type:
    • Tablets
    • Capsules
    • Soft Gels
    • Others (powders, gummies, liquids)
  • Global Eye Health Supplement Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Eye Health Supplement Market, By Region:
    • North America
      • By Country:
      • U.S.
      • Canada
      • By Ingredients Type:
      • Lutein and Zeaxanthin
      • Omega3- Fatty acids
      • Vitamin A
      • Beta-carotene
      • BilBerry extracts
      • Others
      • By Indication Type:
      • Age-related Macular Degeneration (AMD)
      • Cataract
      • Dry Eye Syndrome
      • Glaucoma
      • Others
      • By Dosage Type:
      • Tablets
      • Capsules
      • Soft Gels
      • Others (powders, gummies, liquids)
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Europe
      • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
      • By Ingredients Type:
      • Lutein and Zeaxanthin
      • Omega3- Fatty acids
      • Vitamin A
      • Beta-carotene
      • BilBerry extracts
      • Others
      • By Indication Type:
      • Age-related Macular Degeneration (AMD)
      • Cataract
      • Dry Eye Syndrome
      • Glaucoma
      • Others
      • By Dosage Type:
      • Tablets
      • Capsules
      • Soft Gels
      • Others (powders, gummies, liquids)
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Asia Pacific
      • By Country:
      • Australia
      • India
      • China
      • Japan
      • ASEAN
      • South Korea
      • Rest of APAC
      • By Ingredients Type:
      • Lutein and Zeaxanthin
      • Omega3- Fatty acids
      • Vitamin A
      • Beta-carotene
      • BilBerry extracts
      • Others
      • By Indication Type:
      • Age-related Macular Degeneration (AMD)
      • Cataract
      • Dry Eye Syndrome
      • Glaucoma
      • Others
      • By Dosage Type:
      • Tablets
      • Capsules
      • Soft Gels
      • Others (powders, gummies, liquids)
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Latin America
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • By Ingredients Type:
      • Lutein and Zeaxanthin
      • Omega3- Fatty acids
      • Vitamin A
      • Beta-carotene
      • BilBerry extracts
      • Others
      • By Indication Type:
      • Age-related Macular Degeneration (AMD)
      • Cataract
      • Dry Eye Syndrome
      • Glaucoma
      • Others
      • By Dosage Type:
      • Tablets
      • Capsules
      • Soft Gels
      • Others (powders, gummies, liquids)
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Middle East
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
      • By Ingredients Type:
      • Lutein and Zeaxanthin
      • Omega3- Fatty acids
      • Vitamin A
      • Beta-carotene
      • Bilberry extracts
      • Others
      • By Indication Type:
      • Age-related Macular Degeneration (AMD)
      • Cataract
      • Dry Eye Syndrome
      • Glaucoma
      • Others
      • By Dosage Type:
      • Tablets
      • Capsules
      • Soft Gels
      • Others (powders, gummies, liquids)
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Africa
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
      • By Ingredients Type:
      • Lutein and Zeaxanthin
      • Omega3- Fatty acids
      • Vitamin A
      • Beta-carotene
      • Bilberry extracts
      • Others
      • By Indication Type:
      • Age-related Macular Degeneration (AMD)
      • Cataract
      • Dry Eye Syndrome
      • Glaucoma
      • Others
      • By Dosage Type:
      • Tablets
      • Capsules
      • Soft Gels
      • Others (powders, gummies, liquids)
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
  • Company Profiles
    • Pfizer Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Bausch Health Companies Inc.
    • Alcon Laboratories, Inc.
    • Alliance Pharma PLC
    • Allied Biotech Corporation
    • BASF SF
    • Amway Corp
    • Butterflies Healthcare Ltd.
    • Herbalife Nutrition Ltd.
    • SUSS Technology Corp.
    • EyeScience Labs
    • Nordic Naturals
    • Vitabiotics Ltd.
    • Akorn Incorporated

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3791

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Ingredient Type
  • Market Snippet, By Indication Type
  • Market Snippet, By Form
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis

4. Global Eye Health Supplements Market, By Ingredient Type, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Lutein and Zeaxanthin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Polyvinyl Chloride (PVC)
    • Non-polyvinyl Chloride
    • Antioxidants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Omega-3 Fatty Acids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Coenzyme Q10
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Flavonoids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Astaxanthin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Alpha-Lipoic Acid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Other Ingredients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends

5. Global Eye Health Supplements Market, By Indication Type, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Age-related Macular Degeneration (AMD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Cataract
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Dry Eye Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Other Indications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Eye Health Supplements Market, By Form, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Tablet
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Capsule
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Eye Health Supplements Market, By Regions, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • Bausch + Lomb
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vitabiotics Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Valeant Pharmaceuticals International Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Life Extension
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • OmniActive Health Technologies
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Algatechnologies
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alliance Pharma
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • The Nature's Bounty Co.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amway Corp.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!